The U.S. drug industry’s main lobbying group said it filed alawsuit challenging the constitutionality of a California law meant to make drug prices more transparent.
The state law “attempts to dictate national health-care policyrelated to drug prices in violation of the United StatesConstitution,” the Pharmaceutical Research and Manufacturers ofAmerica said in a statement Friday.
The California measure, signed in October by Governor Jerry Brown, isamong the most aggressive efforts by states to peel back thesecretive process of setting drug prices. The law requirespharmaceutical companies to notify insurers and government healthplans at least 60 days before a planned price increase of more than16 percent during a two-year period, and to explain the rationalefor the increase. The information would be available on agovernment website.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
